Comparison of the efficacy of treatment with clobetasol propionate or bexarotene in early-stage mycosis fungoides
Open Access
- 30 December 2024
- journal article
- research article
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (2) , 237-242
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTCBlood, 2022
- European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017European Journal of Cancer, 2017
- Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)Journal of the American Academy of Dermatology, 2014
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- WHO-EORTC classification for cutaneous lymphomasBlood, 2005
- Topical bexarotene therapy for patients with refractory or persistent early-stage cutaneous T-cell lymphoma: results of the phase III clinical trialJournal of the American Academy of Dermatology, 2003
- Phase 1 and 2 Trial of Bexarotene Gel for Skin-Directed Treatment of Patients With Cutaneous T-Cell LymphomaArchives of Dermatology, 2002
- Topical Corticosteroids for Mycosis FungoidesArchives of Dermatology, 1998
- Glucocorticoid-induced Apoptosis of Lymphoid CellsInternational Archives of Allergy and Immunology, 1994
- A Randomized Trial Comparing Combination Electron-Beam Radiation and Chemotherapy with Topical Therapy in the Initial Treatment of Mycosis FungoidesNew England Journal of Medicine, 1989